Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
WORLD / Science & Health / FOCUS
May 9, 2023
Drugs developed to treat diabetes may offer new approach against Alzheimer's
Experts hope that by improving glucose metabolism, and tamping down inflammation in the entire body, they can slow progression of diseases like Alzheimer's and Parkinson's.
Japan Times
WORLD / Science & Health
May 5, 2023
Experimental Alzheimer's drug slowed disease by 35% in trial, Eli Lilly reports
The results provide what experts say is the strongest evidence yet that removing sticky amyloid plaques from the brain benefits patients with the fatal disease.
Japan Times
WORLD / Science & Health
May 4, 2023
First RSV vaccine caps 60-year search to stem pervasive lung illness
The U.S. Food and Drug Administration cleared GSK’s shot against respiratory syncytial virus on Wednesday. The product will go on sale in the coming weeks for older adults.
Japan Times
BUSINESS
May 1, 2023
Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments
The deal marks the fifth major overseas acquisition by Astellas, Japan's third biggest drugmaker by sales, since 2019.
Japan Times
ASIA PACIFIC
Apr 30, 2023
Mystery middleman may offer clues to Indian-made cough syrup deaths
The deaths of more than 70 Gambian children from acute kidney Injury were linked by global health officials to cough syrups made in India.
Japan Times
COMMENTARY / World
Apr 21, 2023
Cancer vaccine hunt makes progress, finally
A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
WORLD
Apr 20, 2023
As U.S. Supreme Court pauses abortion pill case, what happens next?
A lower court order imposing significant restrictions on the distribution of the abortion drug mifepristone stems from a lawsuit brought by anti-abortion groups seeking to ban the pill.
Japan Times
COMMENTARY / World
Apr 19, 2023
Abortion pill rulings to impact pharmaceutical innovation
Bringing new drugs to market is already expensive and time-consuming. Undercutting the FDA will only make it harder.
Japan Times
WORLD / Science & Health
Apr 17, 2023
Moderna-Merck cancer vaccine plus Keytruda delays recurrence of skin cancer
The findings of the recent trial suggest that adding a personalized cancer vaccine to antibody-based immunotherapy could prolong the time patients have without death or the cancer's return.
Japan Times
WORLD / Politics
Apr 15, 2023
U.S. Supreme Court hits pause on abortion pill ban
The U.S. Supreme Court on Friday temporarily preserved access to a widely used abortion pill, in an 11th-hour ruling preventing lower court restrictions on the drug from coming into force.
Japan Times
COMMENTARY / World
Apr 12, 2023
Schizophrenia drug may offer much-needed progress
Late-stage data on a treatment in development by Karuna Therapeutics for schizophrenia show promise on sharply reducing harsh side effects.
Japan Times
WORLD
Apr 8, 2023
U.S. judge hands anti-abortion groups partial win in abortion pill challenge
The ruling said the challenge is substantially likely to succeed, with the justice saying that the U.S. Food and Drug Administration had ignored risks in approving the drug mifepristone.
Japan Times
COMMENTARY / World
Apr 5, 2023
Just how dangerous are India’s generic drugs? Very.
The red flags for Indian drugs have been there for years. The world deserves much better than contaminated medicine and children poisoned by cough syrup.
Japan Times
WORLD / Science & Health
Apr 4, 2023
Xanax and Adderall access is being blocked by secret drug limits in U.S.
Patients diagnosed with conditions like anxiety and sleep disorders have become caught in the crosshairs of America’s opioid crisis.
Japan Times
JAPAN
Mar 30, 2023
Japan’s COVID vaccine orders lacked solid estimate of demand, watchdog says
The health ministry failed to show enough grounds for its decision to procure a total of 882 million vaccine doses for the government-funded vaccination drive, the Board of Audit said.
Japan Times
JAPAN
Mar 26, 2023
Japanese man detained in China is employee of drugmaker Astellas
The Japanese government has been seeking the release of the man, in his 50s, as soon as possible. He may be facing spying allegations.
Japan Times
ASIA PACIFIC / Science & Health
Mar 23, 2023
China OKs its first mRNA vaccine, from drugmaker CSPC
CSPC Pharmaceutical Group said its independently developed mRNA vaccine targets some major omicron subvariants.
Japan Times
JAPAN / Science & Health
Mar 22, 2023
Hay fever medicine in high demand amid high pollen count
Sales of hay fever-related items such as anti-inflammatory nasal drugs more than doubled to 210% of last year's figure in the week from Feb. 27.
Japan Times
WORLD / Science & Health / FOCUS
Mar 20, 2023
Vaccine-makers prep bird flu shot for humans 'just in case'
One current outbreak of avian flu has killed a record number of birds and infected mammals, but human cases remain rare.
Japan Times
JAPAN
Mar 10, 2023
Japan reports first death directly linked to COVID-19 vaccine
The woman received a Pfizer shot targeting the omicron variant on Nov. 5 at a mass vaccination center.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'